Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AIMT

Aimmune Therapeutics (AIMT) Stock Price, News & Analysis

Aimmune Therapeutics logo

About Aimmune Therapeutics Stock (NASDAQ:AIMT)

Advanced Chart

Key Stats

Today's Range
$34.49
$34.49
50-Day Range
$34.30
$34.59
52-Week Range
$10.09
$37.00
Volume
N/A
Average Volume
1.71 million shs
Market Capitalization
$2.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AIMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AIMT Stock News Headlines

Aimtron Electronics Ltd (AIMT)
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Aimmune Closes Enrolment in Phase III Peanut Allergy Study
See More Headlines

AIMT Stock Analysis - Frequently Asked Questions

Aimmune Therapeutics, Inc. (NASDAQ:AIMT) issued its quarterly earnings data on Thursday, July, 30th. The biotechnology company reported ($1.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($1.06).

Aimmune Therapeutics (AIMT) raised $124 million in an initial public offering on Thursday, August 6th 2015. The company issued 8,300,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Credit Suisse and Piper Jaffray acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aimmune Therapeutics investors own include Hawkins (HWKN), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Meta Platforms (META), Xtrackers California Municipal Bond ETF (CA) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
7/30/2020
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AIMT
Fax
N/A
Employees
228
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$248.50 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.66 per share
Price / Book
20.78

Miscellaneous

Free Float
N/A
Market Cap
$2.26 billion
Optionable
Optionable
Beta
1.76
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:AIMT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners